Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honar Cherif

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Haematology|May 24, 2014
A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidineTobias Svensson, Onima Chowdhury, Hege Garelius, et al.
Idcases|March 20, 2023
Central catheter-related Gordonia bronchialis bacteremia in an immunocompromised patient: A case report, and literature reviewMohammed Alnajjar, Deena Mudawi, Honar Cherif, et al.
Blood Reviews|August 2, 2025
Caplacizumab for pediatric immune thrombotic thrombocytopenic Purpura: A scoping review of current evidenceAbdulrahman F Al-Mashdali, Samah M Salih, Priyadarshini Asmita Vatsyayan, et al.
Blood Reviews|June 8, 2026
Targeting CD38 in immune thrombocytopenia: Rationale and a scoping review of daratumumabAbdulrahman F Al-Mashdali, Ayman Abdullah Dalol, Leen Haj Saleh, et al.
Acta Haematologica|September 26, 2023
Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf RegionSalem H Alshemmari, Mustaqeem A Siddiqui, Ramesh Pandita, et al.
Vaccine|May 12, 2018
Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL groupTobias Svensson, Magdalena Kättström, Ylva Hammarlund, et al.
Clinical Case Reports|January 16, 2023
Recurrent sideroblastic anemia during pregnancyShehab Mohamed, Firyal Ibrahim, Mohamad Najib Alasafar, et al.
Clinical Hematology International|February 13, 2025
Frontline management of multiple myeloma patients: optimizing treatment for patients in the Gulf regionMahmoud Marashi, Khalil Al Farsi, Hussni Al Hateeti, et al.
Clinical Hematology International|May 12, 2025
Relapsed/refractory multiple myeloma: standard of care management of patients in the Gulf regionAhmad Alhuraiji, Khalil Al Farsi, Kayane Mheidly, et al.
Blood|October 12, 2018
Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopeniaMichael Dickinson, Honar Cherif, Pierre Fenaux, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Haematology|May 24, 2014
A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidineTobias Svensson, Onima Chowdhury, Hege Garelius, et al.
Idcases|March 20, 2023
Central catheter-related Gordonia bronchialis bacteremia in an immunocompromised patient: A case report, and literature reviewMohammed Alnajjar, Deena Mudawi, Honar Cherif, et al.
Blood Reviews|August 2, 2025
Caplacizumab for pediatric immune thrombotic thrombocytopenic Purpura: A scoping review of current evidenceAbdulrahman F Al-Mashdali, Samah M Salih, Priyadarshini Asmita Vatsyayan, et al.
Blood Reviews|June 8, 2026
Targeting CD38 in immune thrombocytopenia: Rationale and a scoping review of daratumumabAbdulrahman F Al-Mashdali, Ayman Abdullah Dalol, Leen Haj Saleh, et al.
Acta Haematologica|September 26, 2023
Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf RegionSalem H Alshemmari, Mustaqeem A Siddiqui, Ramesh Pandita, et al.
Vaccine|May 12, 2018
Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL groupTobias Svensson, Magdalena Kättström, Ylva Hammarlund, et al.
Clinical Case Reports|January 16, 2023
Recurrent sideroblastic anemia during pregnancyShehab Mohamed, Firyal Ibrahim, Mohamad Najib Alasafar, et al.
Clinical Hematology International|February 13, 2025
Frontline management of multiple myeloma patients: optimizing treatment for patients in the Gulf regionMahmoud Marashi, Khalil Al Farsi, Hussni Al Hateeti, et al.
Clinical Hematology International|May 12, 2025
Relapsed/refractory multiple myeloma: standard of care management of patients in the Gulf regionAhmad Alhuraiji, Khalil Al Farsi, Kayane Mheidly, et al.
Blood|October 12, 2018
Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopeniaMichael Dickinson, Honar Cherif, Pierre Fenaux, et al.
Pageof 6